This fast growth has created some high expectations for Hims & Hers stock. It now has a price-to-earnings ratio (P/E) of 79, ...

Hims & Hers Health has seen massive success, aided by the growing use of GLP-1 drugs. Click here to find out why I downgrade ...

Should you invest $1,000 in Hims & Hers Health right now? Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst team just identified wha ...

Hims & Hers (HIMS) doubles revenue, expands margins, and grows subscribers. Zava acquisition triples market potential, ...

Hims & Hers is acquiring digital health provider ZAVA to expand into Europe, aiming to boost revenue and international market ...

Zava has operated in Europe since 2011, preceding Hims by six years. It is a private company, corporately Health Bridge Limited, registered with Companies House in London, and the UK company was ...

The cash-based acquisition – the financial terms of which are not being disclosed – will expand Hims & Hers' presence in the ...

Telehealth platform Hims & Hers is set to acquire UK startup Zava to strengthen its international presence. Meanwhile, ...

Citi is holding firm on its Sell rating for Hims & Hers Health, Inc. (NYSE: HIMS ), according to a report released on June 3, ...

Hims & Hers Health (NYSE: HIMS) experienced a notable uptick in its stock price following the announcement of its planned ...

Still, several growth stocks have delivered jaw-dropping returns this year. These two innovation stocks are primed for ...

George Kurtz, founder and CEO of CrowdStrike, said: "We started the fiscal year with record Q1 large deal and MSSP (managed ...